EMILY CRANE: Open Payments
NPI 1447733902 · ZIONSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 15 payments from 9 companies in 2025. Trend: 2023 $342 · 2024 $364 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $42 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, MOUNJARO, Wegovy, GVOKE HYPOPEN, QULIPTA, Veozah, BREZTRI, PREVNAR 20.
Industry payments across IN — which companies pay providers there.
